Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1998 Mar;89(3):328-33.
doi: 10.1111/j.1349-7006.1998.tb00566.x.

Intrinsic sensitivity of tumor cells to bleomycin as an indicator of tumor response to electrochemotherapy

M Cemazar  1 , D Miklavcic, G Sersa
Affiliations

Intrinsic sensitivity of tumor cells to bleomycin as an indicator of tumor response to electrochemotherapy

M Cemazar et al. Jpn J Cancer Res. 1998 Mar.

Abstract

Electrochemotherapy (ECT) involves the use of locally applied electric pulses to increase delivery of chemotherapeutic drugs into cells in tissues. ECT with bleomycin (BLM) is a very effective local treatment, but different tumors have different response rates to ECT. The aim of our study was to compare the responsiveness of SA-1 and EAT tumors to BLM and ECT in vitro and in vivo, in order to find possible reasons for the observed difference in response rate. The difference in sensitivity to ECT in vitro between the SA-1 and EAT cells was 10-fold and was the same as the difference in sensitivity to chronic BLM exposure, as measured by tetrazolium-based colorimetric (MTT) assay. This difference in sensitivity between SA-1 and EAT to ECT was also reflected in tumor cure rate. A six-times lower dose of BLM was needed to obtain local tumor control in SA-1 than in EAT tumors. Therefore, we suggest that the difference in sensitivity to BLM and ECT predominantly reflects the difference in intrinsic sensitivity of the cells to BLM.

PubMed Disclaimer

References

    1. ) Haskell , C. H.Drugs used in cancer chemotherapy . In“Cancer Treatment ,” ed. Haskell C. H. , pp. 63 – 65 ( 1990. ). WB Saunders Co.
    1. ) Mir , L. M. , Tounekti , O. and Orlowski , S.Bleomycin: revival of an old drug . Gen. Pharmacol. , 27 , 745 – 748 ( 1996. ). - PubMed
    1. ) Sidik , K. and Smerdon , M. J.Bleomycin‐induced DNA damage and repair in human cells permeabilized with lysophosphatidylcholine . Cancer Res. , 50 , 1613 – 1619 ( 1990. ). - PubMed
    1. ) Natsugoe , S. , Shimada , M. , Kumanohoso , T. , Tokuda , K. , Baba , M. , Yoshinaka , H. , Fukumoto , T. , Nakamura , K. , Yamada , K. and Nakashima , T.Enhanced efficacy of bleomycin adsorbed on silica particles against lymph node metastasis in patients with esophageal cancer: a pilot study . Surgery , 117 , 636 – 641 ( 1995. ). - PubMed
    1. ) Mir , L. M. , Orlowski , S. , Belehradek , J.Jr. , Teissie , J. , Rols , M. P. , Serša , G. , Miklavčič , D. , Gilbert , R. and Heller , R.Biomedical applications of electric pulses with special emphasis on antitumor electrochemotherapy . Bioelectrochem. Bioenerg. , 38 , 203 – 207 ( 1995. ).

Publication types

LinkOut - more resources